日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Negative hyperselection of patients with stage III colon cancer receiving anti-EGFR-based adjuvant treatment

对接受抗EGFR辅助治疗的III期结肠癌患者进行负向超选择

Ambrosini, M; Blons, H; Garinet, S; Mulot, C; Le Corre, D; Mouillet-Richard, S; Pietrantonio, F; Sroussi, M; Lepage, C; Laurent-Puig, P; Taieb, J

MET exon 14 skipping mutations in non-small-cell lung cancer a 3 years screening experience.

非小细胞肺癌中MET外显子14跳跃突变的3年筛查经验

Dhiab R Ben, Loyaux R, Garinet S, Bastide M, Léonard-Goyet S, Fabre Elizabeth, Mansuet-Lupo Audrey, Gibault Laure, Jouveshomme S, Giroux-Leprieur E, Leroy K, Wislez M, Blons H

Encorafenib, binimetinib and cetuximab in BRAF V600E-mutated advanced pancreatic adenocarcinoma

Encorafenib、binimetinib 和 cetuximab 治疗 BRAF V600E 突变型晚期胰腺腺癌

Zaanan, A; Dabout, V; Garinet, S; Giraud, D; Perkins, G; Taieb, J; Gallois, C